Table 3

Clinical and cognitive comparisons of late hallucinators and non-hallucinators

Late hallucinators (n=13)Late Non-hallucinators (n=42)Statistic
Mean (SD) Mean (SD) t Value
 Age at onset (y)52.0 (10.7)50.0 (9.5)0.62
 Nart IQ108.3 (6.1) (n=11)110.9 (8.7)0.95
 Dose levodopa (mg)614 (433) (n=14)667mg (286) (n=35)0.50
 Dose DA agonist (mg)3.06 (1.76) (n=11)3.11mg (1.85) (n=18)0.07
 Number of drugs2.0 (0.82)1.83 (0.70)0.72
 UPDRS ADL23.2 (7.4)17.8 (8.2)2.03
 UPDRS motor32.3 (14.5)26.1 (12.2)1.48
 AFT right77.1 (48.3) (n=8)73.6 (31.0) (n=30)0.25
 AFT left64.6 (43.7) (n=8)69.4 (23.0) (n=29)0.30
 BDI8.4 (2.9) (n=11)13.0 (7.9)3.063-150
 BDS6.3 (8.1)2.0 (3.0)2.803-150
 LF8.7 (2.7) (n=11)12.2 (3.9)2.813-150
 DO47.1 (25.4) (n=11)62.6 (19.9)2.17
 PR17.9 (3.6) (n=11)19.6 (2.6) (n=41)1.76
 SR12.9 (2.8) (n=11)14.4 (2.8) (n=40)1.56
 SS6.1 (4.1) (n=11)7.6 (2.6) (n=41)1.18
 SWM level 6 between errors17.6 (7.3) (n=10)13.5 (8.2) (n=41)1.45
 SWM level 8 between errors34.3 (11.7) (n=10)30.3 (10.2) (n=40)1.10
 Duration IPD at falls (y)6.50 (4.85) (n=6)7.10 (5.22) (n=17)0.25
 Duration IPD at fluctuation (y)7.72 (5.50) (n=9)5.77 (5.1) (n=24)0.96
 Duration IPD at dyskinesia (y)5.79 (3.24) (n=7)9.14 (5.05) (n=19)1.63
No (%) No (%) χ2 value
 Sex6 female21 female0.006
 Loss of balance10 (83.3)29 (69)10.547**
 Tendency to fall5 (41.7)21 (50)0.033
 Fluctuations8 (66.7)25 (59.5)0.013
 Dyskinesiae7 (58.3)21 (50)0.033
 Levodopa13 (76.5) (n=17)36 (85.7)0.737
 Pergolide12 (70.6) (n=17)15 (35.7)5.9293-150
 Bromocriptine1 (8.3) (n=17)4 (9.5)
 DA agonist13 (76.5) (n=17)18 (42.9)5.4903-150
 Anticholinergics2 (16.7)9 (21.4)0.002
 Selegiline4 (33.3)11 (26.2)0.015
 Apomorphine1 (8.3)2 (4.8)
 Untreated01 (2.4)
  • 3-150 P<0.05; **P<0.01.